Development of azole resistance during fluconazole maintenance therapy for AIDS-associated cryptococcal disease [4]

AIDS

Volumn 15, Issue 17, 2001, Pages 2344-2345

  Friese, Georg ^a   Discher, Thomas ^a   Füssle, Roswitha ^a   Schmalreck, Arno ^a   Lohmeyer, Jürgen ^a  

^a UNIVERSITY HOSPITAL GIESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; VORICONAZOLE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANTIBIOTIC SENSITIVITY; CASE REPORT; CHORIORETINITIS; COMPUTER ASSISTED TOMOGRAPHY; CRYPTOCOCCUS NEOFORMANS; DISEASE COURSE; DRUG BIOAVAILABILITY; FUNGAL MENINGITIS; FUNGUS ISOLATION; HUMAN; LETTER; LYMPHOCYTE COUNT; MALE; MINIMUM INHIBITORY CONCENTRATION; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; RELAPSE; TREATMENT OUTCOME;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; AMPHOTERICIN B; ANTIFUNGAL AGENTS; CHORIORETINITIS; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DRUG RESISTANCE, MULTIPLE, FUNGAL; FLUCONAZOLE; FLUCYTOSINE; HUMANS; ITRACONAZOLE; MENINGITIS, CRYPTOCOCCAL; PNEUMONIA; PREDNISOLONE; PYRIMIDINES; TRIAZOLES;

EID: 0035941394     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200111230-00026     Document Type: Letter

References (5)

1. Cryptococcal meningitis and AIDS
2. Recent advances in the management of cryptococcal meningitis in patients with AIDS
3. Role of fluconazole in the management of AIDS-related cryptococcosis, according to daily dosing
4. The hidden danger of primary fluconazole prophylaxis for patients with AIDS
5. Molecular subtypes and antifungal susceptibilities of serial Cryptococcus neoformans isolates in human immunodeficiency virus-associated cryptococcosis